Comparison of total alkaline phosphatase and three assays for bone-specific alkaline phosphatase in childhood and adolescence

被引:21
作者
Rauch, F
Middelmann, B
Cagnoli, M
Keller, KM
Schonau, E
机构
[1] UNIV MUNICH,KINDERKLIN,ABT PADIATR GENET,D-8000 MUNICH,GERMANY
[2] UNIV BONN,KINDERKLIN,D-5300 BONN,GERMANY
关键词
alkaline phosphatase; bone formation; liver disease; renal failure; X-linked hypophosphatemic rickets;
D O I
10.1111/j.1651-2227.1997.tb08938.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We compared serum levels of total alkaline phosphatase (TAP) and bone-specific alkaline phosphatase (BAP) as determined by three different assays (lectin affinity electrophoresis, immunoradiometric assay, enzyme-linked immunosorbent assay) in subjects aged 5-20 years suffering from X-linked hypophosphatemic rickets (n = 14), chronic renal failure (n = 10) and chronic cholestatic liver disease (n = 16). Results were compared to controls of the same age and were expressed as standard deviation scores (SDS). TAP correlated significantly with BAP (r > 0.9 for each assay; p < 0.001) in controls. In children with cholestatic diseases, TAP (median SDS + 2.0) was elevated, but BAP, as measured by the electrophoretic assay, was within the reference range for most patients (median SDS: -0.4; p = 0.003 for the difference between the median SDS of TAP and BAP). In contrast, results for BAP as determined by the two immunoassays were not significantly different from TAP in any of the three patient groups (p > 0.05 in each group for both assays). In this study, the two immunoassays did not have a detectable advantage over lectin affinity electrophoresis in the determination of BAP.
引用
收藏
页码:583 / 587
页数:5
相关论文
共 21 条
[1]  
BERGMEYER HU, 1972, Z KLIN CHEM KLIN BIO, V10, P182
[2]  
Bouman AA, 1996, CLIN CHEM, V42, P1970
[3]   Molecular basis and clinical application of biological markers of bone turnover [J].
Calvo, MS ;
Eyre, DR ;
Gundberg, CM .
ENDOCRINE REVIEWS, 1996, 17 (04) :333-368
[4]   X-LINKED HYPOPHOSPHATEMIA - EFFECT OF CALCITRIOL ON RENAL HANDLING OF PHOSPHATE, SERUM PHOSPHATE, AND BONE MINERALIZATION [J].
COSTA, T ;
MARIE, PJ ;
SCRIVER, CR ;
COLE, DEC ;
READE, TM ;
NOGRADY, B ;
GLORIEUX, FH ;
DELVIN, EE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 52 (03) :463-472
[5]  
CROFTON PM, 1995, CLIN CHEM, V41, P672
[6]  
CROFTON PM, 1992, CLIN CHEM, V38, P663
[7]  
FARLEY J, 1995, CLIN CHEM, V41, P1551
[8]  
FARLEY JR, 1994, CLIN CHEM, V40, P1749
[9]  
FLEISHER GA, 1977, CLIN CHEM, V23, P469
[10]   ASSESSMENT OF THE SERUM LEVELS OF BONE ALKALINE-PHOSPHATASE WITH A NEW IMMUNORADIOMETRIC ASSAY IN PATIENTS WITH METABOLIC BONE-DISEASE [J].
GARNERO, P ;
DELMAS, PD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (04) :1046-1053